Contrast Media Injectors

Contrast media injectors are used to inject contrast media or contrast agents to enhance the blood and perfusion in tissues.

News | Contrast Media Injectors
Bayer Receives FDA Clearance for CT Injection System

Nov. 7, 2024 — Bayer announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its ...

Time November 08, 2024
arrow
Collaboration includes robust education and training to support radiologists and imaging specialists
News | Mammography
Bayer and Hologic Collaborating to Deliver Contrast-Enhanced Mammography

April 12, 2024 — Bayer and Hologic, Inc. announced a first-of-its-kind collaboration to deliver a coordinated solution ...

Time April 12, 2024
arrow
The latest MyBreastAI Suite supports clinicians in accelerating breast cancer detection, while the company’s Pristina Bright solution helps healthcare providers start a new contrast program
News | Mammography
GE HealthCare to feature Mobile Mammography Screening Truck along with Latest AI Platform as part of SBI2024 Breast Cancer Imaging Showcase

April 12, 2024 — GE HealthCare, a leader in breast health technology and diagnostics, will feature its latest breast ...

Time April 12, 2024
arrow
With its latest evolution, Guerbet reports that it offers advanced performance features to its Optistar Elite.
Feature | Contrast Media Injectors | By Christine Book
Market Analysis: Vendor Focus on Optimizing Patient Safety and Radiology Workflow Drives Growth

Contrast media injectors are used to inject contrast media or contrast agents to enhance the blood and perfusion in ...

Time January 17, 2024
arrow
VUEWAY (gadopiclenol) solution for injection and VUEWAY (gadopiclenol) Pharmacy Bulk Package are available for use in the U.S. following the market launch in February 20231
News | Contrast Media
American College of Radiology Classifies VUEWAY as a Group II Agent Relative to NSF

May 16, 2023 — Bracco Imaging, an innovative world leader delivering end-to-end products and solutions through a ...

Time May 16, 2023
arrow
In the past year, the radiology community has been a first-hand, hands-on witness to myriad unexpected challenges and unprecedented partnerships emerging on the scene of the contrast media market
Feature | Contrast Media | By Christine Book
A Look Inside the Contrast Media Market

In the past year, the radiology community has been a first-hand, hands-on witness to myriad unexpected challenges and ...

Time May 03, 2023
arrow
Sponsored Content | Videos | Contrast Media
VIDEO: Talking Trends with Bracco: Investing in the Future of Radiology

Bracco Diagnostics and Guerbet recently announced they had formed a strategic, global collaboration for the research ...

Time February 27, 2023
arrow
First dosage administered at the Hospital of the University of Pennsylvania following FDA approval
News | Contrast Media
Guerbet Announces Commercial Launch and First Patient Dosing of Elucirem (Gadopiclenol) Injection

February 16, 2023 — Guerbet, a global leader in medical imaging with more than 30 years of experience in MRI, announced ...

Time February 16, 2023
arrow
While the global COVID-19 pandemic took its toll on imaging diagnostics, the market for contrast agent injector systems is poised for significant growth for a range of reasons.
Feature | Contrast Media Injectors | By Christine Book
Contrast Media Injectors: Market Outlook and Opportunities

The vital, and growing role of contrast media, and the medical devices employed to inject the agent into the body ...

Time January 19, 2023
arrow
GE Healthcare will offer its own brand CT Motion injector, an innovative, multi-dose, syringeless technology developed and manufactured by ulrich medical, to a growing injector market in the U.S.
News | Computed Tomography (CT)
GE Healthcare and ulrich medical announce an Agreement to Offer a Branded Multi-dose Contrast Media Injector in the U.S.

December 12, 2022 — GE Healthcare announced an agreement with ulrich medical for a GE Healthcare branded contrast media ...

Time December 12, 2022
arrow
Bracco Diagnostics Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved Gadopiclenol Injection, a new, highly stable macrocyclic gadolinium-based contrast agent (GBCA), in partnership with Guerbet.. 
News | Contrast Media
Bracco and Guerbet Partner to Expand Access to Novel Imaging Agent

Editor’s note: On September 21, 2022, both Guerbet and Bracco Diagnostics released news detailing the FDA approval of a ...

Time September 22, 2022
arrow
EHR screenshot showing sidebar text displayed to referring clinicians after placing orders for body CT (neck, chest, or abdomen and pelvis), describing iohexol shortage and providing appropriate strategies for iodinated contrast media conservation.
News | Contrast Media
EHR Interventions for Contrast Media Shortage Impact CT Utilization

August 3, 2022 — According to an open-access article in ARRS’ American Journal of Roentgenology (AJR), electronic health ...

Time August 03, 2022
arrow
Bracco Diagnostics has announced that the U.S. Food and Drug Administration (FDA) granted import discretion of Iomeron® (iomeprol injection) into the U.S. to address the ongoing iodinated contrast media shortage.
News | Contrast Media
FDA Grants Import Discretion of Bracco’s Iodinated Contrast Medium Iomeron (iomeprol injection) to Address Supply Shortages

August 2, 2022 – A new update has been announced as the radiology world continues to address supply disruptions of ...

Time August 02, 2022
arrow
Iodixanol Injection, USP is the first U.S. FDA-approved generic iso-osmolar, dimeric iodinated contrast media agent, which is used during diagnostic x-ray-based imaging such as computed tomography (CT) scans
News | Contrast Media
Fresenius Kabi Introduces Generic Iodixanol Contrast Media Agent

July 18, 2022 — Fresenius Kabi announced today it will introduce a portfolio of generic contrast media agents in the ...

Time July 18, 2022
arrow
The global contrast media market is projected to reach $5.9 billion by 2026 from $4.9 billion in 2021, at a CAGR of 3.7% during the forecast period.
Feature | Contrast Media
Contrast Media/Contrast Agent Market

The global contrast media market is projected to reach $5.9 billion by 2026 from $4.9 billion in 2021, at a CAGR of 3.7% ...

Time May 03, 2022
arrow
Lawrence N. Tanenbaum, MD FACR is Vice President/Chief Technology Officer Director of CT, MR, and Advanced Imaging for RadNet with 37+ years experience in the medical field. He is a member of editorial boards of several journals/educational organizations and reviewer for scientific journals. He has authored 100+ scholarly and peer-reviewed articles, chairs educational/academic meetings, and has delivered 2000+ invited global lectures.
Sponsored Content | Case Study | Contrast Media Injectors
Case Studies with Lawrence N. Tanenbaum, MD FACR Using Macrocyclic CLARISCAN (gadoterate meglumine) Injection for Intravenous Use

Product Indications and Use: CLARISCAN (gadoterate meglumine) is a gadolinium-based contrast agent indicated for ...

Time May 03, 2022
arrow
NEXO[DOSE] dashboard
Sponsored Content | Blog | Radiation Dose Management
Effective Radiation Dose Management Improves Imaging Practices, Patient Safety and Ensures Compliance

Early-stage detection is key to the prevention of life-threatening diseases; however, limited access to data hinders the ...

Time April 11, 2022
arrow
EmpowerMR Injector System
Sponsored Content | Blog | Contrast Media Injectors
BLOG: Advanced Injector System Provides Greater Control and Accelerates Patient Care

Medical imaging and contrast use have become an integral part of the diagnostic process to determine the best ...

Time February 28, 2022
arrow
Sponsored Content | Blog | Contrast Media Injectors
BLOG: Patient-centric Injector Solutions Help CT Departments Take Control, Improve Safety

Patient safety is a fundamental requirement to all applications of radiology techniques and procedures. As the ...

Time January 21, 2022
arrow
In February 2021, Guerbet announced the launch of OptiProtect 3S (Smart Service Solutions), a range of technical services for its injection solutions. OptiProtect 3S is designed to support imaging centers in the daily use and protection of their injection solutions.
Feature | Contrast Media Injectors | By Melinda Taschetta-Millane
Contrast Media Injectors Market Outlook

Contrast media injectors are used to inject contrast agents to enhance the blood and perfusion in tissues. There have ...

Time January 19, 2022
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now